Dube Michael P
VP, Chief Accounting Officer
CIK: 2019493
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Intellia Therapeutics, Inc. (NTLA) | S | 2,641 | $16.78 | $44,315.98 | View Details Filing |
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Intellia Therapeutics, Inc. (NTLA) | S | 2,641 | $16.78 | $44,315.98 | View Details Filing |